06-Apr-17 In Japanese companies' largest study to date, Takeda will test an experimental dengue vaccine on 20,100 children and adolescents in eight countries in Latin America. Takeda said it has completed enrollment for a 20,000-subject dengue vaccine trial, the largest clinical study in its history, signalling the global ambitions of its vaccine business. [image: ET Healthworld]

17-Mar-17 TPG, the US alternative-investment firm, sees opportunities in healthcare in Asia to meet untapped demand in some of the fastest-growing economies. The region is short of quality healthcare infrastructure, said Jim Coulter, co-CEO. TPG’s Asian investment arm manages USD6 bn in assets, including a stake in the United Family Healthcare chain of high-end Chinese hospitals. [image: Bloomberg]

10-Feb-17 Carl Zeiss Meditec reported a 6.6% increase in revenue to €280 million in the first quarter of its 2016-2017 fiscal year, compared with €262.2 million in the same quarter a year ago. In the Asia-Pacific region, revenue increased 26.6% from €83.6 million to €105.8 million, attributed to the Chinese market and Southeast Asia and India. [image: Carl Zeiss]

26-Jan-17 The medical and surgical aesthetics market grew a further 8.3 percent in 2016. Representing 46 percent of global market share, the USA still leads the way, followed by Europe, Asia-Pacific and Latin America, according to annual figures from IMCAS. Global growth is above all driven by Asia, which saw annual growth of 10 percent in 2016. [image: The Malay Mail Online]

24-Jan-17 GE Healthcare had a strong 2016 fourth quarter performance led by 19 percent growth in China. For 2017, the company expects momentum to carry over for markets in China, Africa, and Asia Pacific, while Europe will be stable. The United States market is expected to slow down. Sales were boosted by ultrasound, up 6 percent, and imaging, up 2 percent. [image: GE Healthcare]